Overview
News
Salaries
Products
People
Growth
Offices
Financials
News
Lexitas Announces Improved User Experience for eLaw Case Tracking
HOUSTON, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Lexitas, a leading provider of technology enabled litigation support services, announced an improved...
Read more
Report
For Sponsors
Lexitas is an ophthalmology contract research organization that supports your clinical trial at every phase with unmatched clinical and regulatory expertise.
Read more
Report
Behind the Acquisition: Lexitas Pharma Services & Erie Retina Research
Lexitas CEO Jeanne Hecht and Chief Retina Strategy Officer Dr. David Almeida discuss the recent acquisition of Erie Retina Research.
Read more
Report
The Need for Speed: Why vertical integration is the key to streamlining complex retina clinical trials
Lexitas CEO, Jeanne Hecht, and Chief Retina Strategy Officer, David Almeida discuss vertical integration for complex retina clinical trials.
Read more
Report
Lexitas Leaders to Lead AI Roundtable at Women, Influence & Power in Law Conference 2026
HOUSTON, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Lexitas, a leading provider of technology enabled litigation support services, announced today that ...
Read more
Report
Best Corrected Visual Acuity: Still the Gold Standard in Clinical Trials-But for How Long?
Lexitas CMO, David Tanzer, MD, and Senior Director Nevin El-Nimri, OD, PhD, discuss BCVA as a primary clinical endpoint in a recent Eyes on Eyecare article.
Read more
Report
Lexitas and NAMSA Announce Strategic Partnership to Deliver End-to-End Ophthalmic Medical Device Development
End-to-end ophthalmic medical device development with Lexitas' dedicated ophthalmology expertise embedded in NAMSA's end-to-end MedTech development platform
Read more
Report
Lexitas Pharma Services Announces the Acquisition of Erie Retina Research, CASExERIE and Element Erie
Lexitas Pharma Services Announces the Acquisition of Erie Retina Research, CASExERIE and Element Erie. Dr. David Almeida joins as Chief Retina Strategy Officer.
Read more
Report
Octane Welcomes Lexitas Pharma Services as Newest Octane Preferred Advisor
Leading ophthalmology CRO joins Octane's network to support early-stage and emerging companies developing vision-restoring innovations
Read more
Report
Advisory Board
Lexitas' Advisory Board brings together leaders across ophthalmology to shape our strategic vision and drive growth and innovation for our customers.
Read more
Report
Show more news
Growth
Hiring Momentum
44/100
Stable
Open positions
3
1 opened / 0 closed in 30 days
ATS activity
Every ~5 hours
Today
Hiring Dynamics
0%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Legal
50% ▲
Public Policy
50% ▼
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Durham
United States
HQ
Lexitas Pharma Services, Inc.
50-200 est. staff
5425 Page Road, Suite 410, Durham, NC 27703
